Earum Pharmaceuticals IPO
Company Info: Earum Pharmaceuticals Limited is engaged in the pharmaceutical business involving marketing, trading and distribution of a wide range of pharmaceutical formulation products. The company has 125 drugs formulation products including multivitamins, gynaecology drugs, steroids, antibiotic drugs, cerebral activator drugs, gastrointestinal drugs, etc
Date of Incorporation:
Earum Pharmaceuticals Limited was incorporated as “Earum Pharmaceuticals Private Limited” on July 26, 2012.
Promoters of the Company:
The Promoters of this company are Mr. Bhumishth Narendrabhai Patel and Mrs. Payal Bhumishth Patel.
Strengths of the company:
Diversified Product Portfolio
Experienced Promoter and Management Team
Quality Assurance
Objective of the Company:
Funds for the working capital requirements of the company
Payment/ Repayment of the unsecured loans availed from banks and financial institutions of the company.
Company Financial:
30-Dec-18 | 31-Mar-18 | 31-Mar-17 | 31-Mar-16 | |
Total Assets | 2,741.00 | 22,492.59 | 1,108.45 | 878.71 |
Total Revenue | 3,450.35 | 3,584.65 | 2,369.27 | 1,863.00 |
Total Expenses | 3,330.69 | 3,460.51 | 2,369.27 | 1,846.96 |
Profit after tax | 86.51 | 85.65 | 15.98 | 9.76 |
Issue Detail
- Issue Open: Jun 21, 2019
- Issue Close: Jun 26, 2019
- Issue Type: Fixed Priced Issue IPO
- Face Value: Rs 10 per equity share
- Price Band: Rs 36 per equity share
- Bid Lot:3000 Shares
- Minimum Order Quantity:3000 Shares
- Listing At: BSE SME
-
Issue Size:
Rs 6.65 Cr
Current Bidding Status
| Number of Times Subscribed (BSE + NSE) | |||||||
|---|---|---|---|---|---|---|---|
| As on Date & Time | QIB | NII | RII | Employee | Others | Total | |
Listing Day Trading Information
| - | BSE | NSE |
|---|---|---|
| Issue Price | ||
| Open | ||
| Low | ||
| High | ||
| Last Trade | ||
| Volume |